文献速递母胎医学产科

尺寸选择性胎盘游离DNA富集用于胎儿拷贝数变异无创产前检测的临床性能评估

Clinical Performance Evaluation of Size-Selective Placental Cell-Free DNA Enrichment for Non-Invasive Prenatal Testing of Fetal Copy Number Variants.
PubMed 文献 · Prenat Diagn · 2026-10-04

本研究回顾性分析86,012例接受尺寸选择性游离DNA富集低深度NIPT的孕妇,以CMA验证阳性病例。总体CNV阳性率0.39%,总PPV为59.20%;22q11.21缺失最常见(16.76%),其PPV为40.00%。胎儿分数升高可提高断点准确性。

要点

  • 尺寸选择性cfDNA富集NIPT的CNV总阳性率为0.39%,总PPV为59.20%。
  • 22q11.21缺失最常见(占16.76%),但其PPV仅40.00%。
  • 胎儿分数升高有助于提高CNV断点验证的准确性。

核心结论

  • 尺寸选择性游离DNA富集低深度NIPT对胎儿CNV检测具有临床可行性,胎儿分数升高可改善断点准确性。

研究设计与样本

  • 回顾性分析86,012例接受尺寸选择性游离DNA富集NIPT的孕妇,采用隐马尔可夫模型检测CNV,阳性病例经染色体微阵列分析(CMA)验证。

主要发现

  • DNA富集后平均胎儿分数为18.88%±5.82%。
  • 339例孕妇共检出340个CNV,总体CNV阳性率为0.39%[95%CI:0.35%,0.44%](339/86,012),包括249个缺失和91个重复。
  • CNV总PPV为59.20%[95%CI:52.05%,66.00%](119/201)。
  • 与CMA相比,85.83%[95%CI:78.01%,91.29%](103/120)的CNV大小差异<25%,80.42%[95%CI:74.71%,85.13%](193/240)的断点位于1 Mb以内。
  • 22q11.21缺失最常见,占16.76%[95%CI:13.04%,21.26%](57/340),其PPV为40.00%[95%CI:25.28%,56.61%](16/40)。

临床怎么用

  • 该富集NIPT可用于胎儿CNV的无创产前筛查,阳性结果需经CMA确诊。
  • 胎儿分数较高时CNV断点定位更准确,解读结果时应关注胎儿分数。
  • 22q11.21缺失虽最常见但PPV较低,阳性后应谨慎咨询并建议确诊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the performance of low-depth non-invasive prenatal testing (NIPT) using cell-free DNA enrichment for detecting fetal copy number variations (CNVs) and to assess its clinical utility. METHODS: A retrospective analysis was conducted on 86,012 pregnant women who underwent NIPT with size-selective cell-free DNA enrichment. CNVs were detected using a Hidden Markov Model. Following prenatal diagnosis of positive cases through chromosome microarray analysis (CMA), positive predictive values (PPVs) were evaluated across different CNV sizes and fetal fractions, and the accuracy of CNV breakpoint validation was assessed. RESULTS: DNA enrichment achieved a mean fetal fraction of 18.88% ± 5.82%. A total of 340 CNVs were detected in 339 pregnant women, with an overall CNV positive rate of 0.39% [95% CI: 0.35%, 0.44%] (339/86, 012), including 249 deletions and 91 duplications. The total PPV for CNVs was 59.20% [95% CI: 52.05%, 66.00%] (119/201). For the accuracy of CNV size and position, 85.83% [95% CI: 78.01%, 91.29%] (103/120) of CNVs had size discrepancies < 25% compared to CMA, and 80.42% [95% CI: 74.71%, 85.13%] (193/240) of breakpoints were within 1 Mb. The 22q11.21 deletion was the most frequent CNV (16.76% [95% CI: 13.04%, 21.26%] (57/340)), with a PPV of 40.00% [95% CI: 25.28%, 56.61%] (16/40). CONCLUSION: An elevated fetal fraction improves breakpoint accuracy. In addition to increasing sequencing depth, it represents a promising technical approach to optimizing the performance of NIPT.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Liu X, Cao X, Hu L, et al. Clinical Performance Evaluation of Size-Selective Placental Cell-Free DNA Enrichment for Non-Invasive Prenatal Testing of Fetal Copy Number Variants. Prenat Diagn. 2026. PMID: 42829957. doi:10.1002/pd.70262

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。